logo
Plus   Neg
Share
Email

China Pharma Q1 Net Loss Widens - Quick Facts

China Pharma Holdings Inc. (CPHI) reported that its first-quarter net loss widened to $0.7 million or $0.02 per share, from $0.4 million or $0.01 per share last year, as a result of decreased revenue, whereas the expenditures did not decrease in proportion to revenue due to fixed costs.

Zhilin Li, China Pharma's Chairman and CEO, said, "The current outbreak of COVID-19 has had a material and adverse effect on the Company's business operations. We had experienced disruptions and restrictions on our ability to travel and to distribute our products, as well as temporary closures of our facilities or the facilities of the suppliers or customers."

Revenue for the quarter decreased 39.8% to $1.8 million from last year's $2.9 million, due to the negative impact of the outbreak of COVID-19.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said that the current state of the COVID-19 pandemic in the U.S. is "really not good." The U.S. is the country worst-affected by the coronavirus and has recently seen a surge in coronavirus infections as lockdown restrictions are eased. Granules Pharmaceuticals, Inc. recalled twelve (12) lots of type 2 diabetes medication Metformin hydrochloride Extended-Release, in the form of oral film-coated tablets, for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA), above levels of the Acceptable Daily Intake Limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement. Palantir Technologies Inc., the Silicon Valley big data analytics company that has handled U.S. government's certain sensitive projects, said it has confidentially filed documents with the Securities and Exchange Commission to go public. In a statement, the company said the proposed public listing of its Class A common stock is expected to take place after the SEC completes its review process.
RELATED NEWS
Follow RTT